3,4-Methylenedioxymethamphetamine (MDMA or "Ecstasy") is a widely abused, psychoactive recreational drug. There are growing evidences that the MDMA neurotoxic profile may be highly dependent on its hepatic metabolism. MDMA metabolism leads to the production of highly reactive derivates, namely catechols, catechol thioethers, and quinones. In this study the electrochemical oxidation-reduction processes of MDMA human metabolites, obtained by chemical synthesis, were evaluated by cyclic voltammetry based on an electrochemical cell with a glassy carbon working electrode. The toxicity of α-methyldopamine (α-MeDA), N-methyl-α-methyldopamine (N-Me-α-MeDA) and 5-(glutathion-S-yl)-α-methyldopamine [5-(GSH)-α-MeDA] to rat cortical neurons was then correlated with their redox potential. The obtained data demonstrated that the lower oxidation potential observed for the catecholic thioether of α-MeDA correlated with the higher toxicity of this adduct. This accounts for the use of voltammetry data in predicting the toxicity of MDMA metabolites.
INTRODUCTION
The research in the area of drug abuse is mainly focused in its direct or indirect effects on receptors and transmitters 1) and less attention has been given to the putative chemical reactivity of their metabolic products. However, there are overwhelming evidences indicating that metabolites are often crucial participants in the action of drugs and toxins.
The ring-substituted amphetamines, 3,4-Methylenedioxymethamphetamine (MDMA), 1 and methylenedioxyam-phetamine (MDA), 2 are well established serotonergic neurotoxicants. 2, 3) MDMA, also known as "Ecstasy," is a widely abused psychoactive recreational drug associated with acute and long-term toxic effects. MDA, a well characterized metabolite of MDMA, has also been used as a drug of abuse. Various studies in laboratory animals and humans have been demonstrating that the exposure to MDMA may elicit long-term changes in the neurochemistry and behavior. These changes result from the selective neurotoxicity to the 5-hydroxytryptamine (5-HT) containing axon terminals. 4) Systemic metabolism seems important for the neurotoxic response since, in some animal studies, direct injection of MDA or MDMA into the brain did not cause long-term 5-HT deficits. [5] [6] [7] The metabolism of MDMA and MDA starts with Odemethylenation to N-methyl-α-methyldopamine (N-Me-α-MeDA), 3 and α-methyldopamine (α-MeDA), 4 respectively, both of which are catecholamines that can undergo oxidation to the corresponding ortho-quinones 5 and 6 (for detailed insights on MDMA metabolism see Fig. 1 ). 8, 9) These quinones are highly active redox molecules, which can enter redox cycles with their semiquinone radicals, leading to formation of reactive oxygen species (ROS) and reactive nitrogen species (RNS). 10, 11) The toxicity of these metabolites has been corre- lated with electron transfer (ET), ROS formation and consequent oxidative stress (OS). 12, 13) A cyclic voltammetry study on the oxidation-reduction behavior of bioactive catecholamines 14, 15) showed the straightforward formation of the corresponding oquinones via electro-oxidation (a two electron transfer process). These o-quinones can readily undergo reduction, indicating the potential for ET occurrence in vivo. Alternatively, the reactive o-quinone intermediates are Michael acceptors, and cellular damage can occur through alkylation of crucial cellular proteins and/or DNA. In the presence of other bionucleophiles, as GSH, o-quinones may conjugate to form adducts. These conjugates remain redox active being in turn readily oxidized to the corresponding quinone-adducts, which are susceptible to an addition of a second nucleophile molecule. 16) Our group has previously evaluated the toxicity of MDMA and three of its metabolites, obtained by synthesis, namely N-Me-α-MeDA, α-MeDA and 5-(glutathion-S-yl)-α-methyldopamine [5-(GSH)-α-MeDA], 7, in rat cortical neuronal serum free cultures under normal (36.5 • C) and hyperthermic (40 • C) conditions. 17) It was shown that these metabolites are more neurotoxic than the parent compound MDMA, being 5-(GSH)-α-MeDA the most toxic. We have also previously demonstrated that the metabolism is important for MDMA-induced toxicity to peripheral organs. [18] [19] [20] The underlying mechanisms of MDMA and MDA-induced neurotoxicity, namely the toxic effects mediated by its metabolite(s), remain to be completely elucidated. Herein we present cyclic voltammetry studies that provide evidence for a correlation between the toxicity of MDMA and MDAmetabolites and their redox potential.
MATERIALS AND METHODS
Reagents and Apparatuses --N-Acetylcysteine (NAC), GSH, mushroom tyrosinase (4400 units/mg) and other chemicals were obtained from Sigma-Aldrich R (Steinheim, Germany). MDMA (HCl salt) was extracted and purified from high purity MDMA tablets that were provided by the Portuguese's Criminal Police Department. The obtained salt was pure and fully characterized by NMR and mass spectrometry methodologies.
Solvents were dried by standard methods 21) and distilled before use. Analytical thin-layer chromatography was conducted on Merck (Darmstadt, Germany) Kieselgel 60, F254 silica gel 0.2 mm thick plates; column chromatography was performed on Merck Kieselgel 60 (240-400 nm) silica gel or reverse-phase RP-18 modified silica. Melting points were recorded on a Reichert-Thermovar hot stage apparatus and are reported uncorrected. InfRaRed (IR) spectra were recorded on a Perkin Elmer (Beaconsfield, UK) Spectrum 1000 as potassium bromide (KBr) pellets or as film over sodium chloride (NaCl) windows. UV/vis spectra were recorded between 200 and 500 nm on a Thermo Electron Helios γ. Proton and carbon nuclear magnetic resonance spectra ( 1 H-and 13 C-NMR) were recorded on a Bruker (Wissembourg, France) ARX 400 spectrometer at 400 and 100.62 MHz respectively. Chemical shifts are expressed in ppm, downfield from trimethylsilyl (TMS, δ = 0) as an internal standard; J-values are given in Hz. The exact attribution of NMR signals was preformed using two dimensional NMR experiments. Low resolution mass spectra were acquired with a Micromass (Manchester, UK) GC-TOF Gas Chromatogra-phy Time-of-fly (GCT) mass spectrometer. HPLC was conducted on a Merck Hitachi (Tokyo, Japan) system consisting of an L-7100 pump, a Rheodyne type injector, a D-7000 interface, and an L7450A diode array spectrometric detector. Cyclic voltammograms were run at room temperature on an Autolab (Utrecht, Netherlands) PGSTAT12 potentiostat connected to a conventional three-electrode cellassembly (saturated calomel electrode (SCE) as reference, Pt wire as counter electrode and glassy carbon as working electrode).
Chemical Synthesis
Hydrobromide salts of N-methyl-α-methyldopamine (3) and α-methyldopamine (4). N-Me-α-MeDA.HBr and α-MeDA.HBr were prepared following the procedures of Borgman 22) and Pizarro 23) starting from the corresponding benzaldehyde and nitroethane.
Hydrobromide salt of 1-(3 ,4 ,5 -Trihydroxyphenyl)-2-aminopropane (5-OH-α-MeDA, 13) was prepared following the previously procedure starting from the corresponding 3,4,5-trimethoxybenzaldehyde and nitroethane.
Trans-1-(3 ,4 ,5 -trimethoxyphenyl)-2-nitropropene. Obtained in 50% yield. Recristalized from ethanol/water, mp 97-98 • C [lit. 24) 4 (0.4 g, 0.01 mol) in dry tetrahydrofuran (THF, 10 ml) was added dropwise a solution of trans-1-(3 ,4 ,5 -trimethoxyphenyl)-2-nitropropene (1 g, 3.97 × 10 −3 mol) in THF (10 ml). The solution was refluxed for 3 hr after which the excess of LiAlH 4 was destroyed by slow addition of 2 ml of water followed by 2 ml of aqueous 15% NaOH and finally 5 ml of water. The mixture was filtered and the residue washed with THF. The solution was dried with anhydrous Na 2 SO 4 and evaporated to dryness. The yellow oil was dissolved in hexane and the compound precipitated by freezing. The product was obtained as its hydrochloride salt by precipitation of the salt by slow addition of an HCl dry ethyl ether solution: mp 221-223 • C (lit. 25) Synthesis of the conjugated adducts of N-methyl-α-methyldopamine and α-methyldopamine with GSH and NAC.
Me-α-MeDA, (10)] were prepared according to previously published methods 26, 27) with the modifications reported bellow.
5-(GSH)-α-MeDA (7) and 2-(Glutathion-Syl)-α-methyldopamine hydrobromide [2-(GSH)-
To a solution of 4 as hydrobromide salt (0.020 g, 8.06 × 10 −5 mol) in sodium phosphate buffer (80 ml, pH 7.4, 50 mM) at 25 • C it was added mushroom tyrosinase (8000 units, 100 U/ml buffer). The solution became red, indicating the formation of o-quinone. GSH (0.124 g, 4.03 × 10 −4 mol) was added and the solution red color changed with time to yellow (1 hr). The solution was carefully concentrated by rotary evaporation at room temperature and diluted in 1 ml of water. The product's purification was performed by reverse-phase RP-18 modified silica column chromatography, first with water (150 ml) and then the product separated using 10×7.5 ml of formic acid/water/methanol (1:49:50). Each fraction was checked for the presence of adduct using a UV/vis detector. Fractions containing maxima at 264 and 294 nm were separated and lyophilized to dryness. Product 7 (2.7 × 10 −2 g) was obtained as an oil in 60% yield and the adduct 11 (1.6 × 10 −3 g) also as an oil in 3.1% yield. The compound's purity was checked by HPLC using a LiChrospher 100 RP-18 column, with two mobile phase solvents. Solvent A was prepared by adding concentrated trifluoroacetic acid (TFA) to deionized water until pH was 2.15. Solvent B was prepared by adding TFA to a 1:1 mixture of acetonitrile (MeCN) and deionized water until pH 2.15. The following mobile phase gradient was used: 0-2 min, 100% of solvent A; 2-10 min, 100-65% of solvent A; 10-20 min, 65-0% of solvent A; 20-25 min, 100% of solvent B; 25-30 min 100% of solvent A. The compounds 7 and 11 eluted in 13 and 11.7 min respectively. The peaks were monitored at 290 nm. 5- 
5-(GSH)-N-Me-α-MeDA (8).
To a solution of 3 as hydrobromide salt (2 × 10 −2 g, 7.6 × 10 −5 mol) in sodium phosphate buffer (35 ml, pH 7.4, 50 mM) at 25 • C it was added mushroom tyrosinase (3500 units, 100 U/ml buffer). The solution became red, indicating the formation of oquinone. GSH (0.11 g, 3.82 × 10 −4 mol) was added and the solution red color changed with time to yellow (3 hrs). The solution was carefully concentrated by rotary evaporation without heating and dissolved in 1 ml of water. The product purification was performed by reverse-phase RP-18 modified silica column chromatography using the following gradient: water (200 ml), 10% methanol (MeOH) (100 ml), 20% MeOH (50 ml) and 50% MeOH (column wash). Each fraction was checked for the presence of adduct using a UV/vis detector. Fractions containing maxima at 232, 264 and 294 nm were separated and lyophilized to dryness. The product 8 (3.2 × 10 −2 g) was obtained as oil in 74% yield; 1 At the terminus of the reaction 1 ml of formic acid 88% was added and the solution was carefully concentrated by rotary evaporation without heating and dissolved in 1 ml of formic acid 1%. The product's purification was performed by reverse-phase RP-18 modified silica column chromatography using the following gradient: water (200 ml), 10% MeOH (100 ml), 20% MeOH (50 ml) and 50% MeOH (column wash). Each fraction was checked for the presence of the adduct using a UV/vis detector. Fractions containing maxima at 264 and 294 nm (eluted with 10% MeOH) contained the adduct 12 and fractions containing maxima at 267 and 297 nm (eluted with 20% MeOH) contained the adduct 9 were separated and lyophilized to dryness. Compound 9 (9.0 × 10 −3 g) was obtained as an oil in 28% and compound 12 (1.0 × 10 −3 g) also as an oil in 3.0%. To a solution of 3 as hydrobromide salt (2.5 × 10 −2 g, 9.54 × 10 −5 mol) in sodium phosphate buffer (50 ml, pH 7.4, 50 mM) at 25 • C it was added mushroom tyrosinase (3500 units, 132 U/ml buffer). The solution became red, indicating the formation of o-quinone. NAC (7.8 × 10 −2 g, 4.77 × 10 −4 mol) was added and the solution red color changed with time to yellow (2 hrs). At the terminus of the reaction 1 ml of formic acid 88% was added and the solution yellow color change immediately to green. The solution was carefully concentrated by rotary evaporation without heating and dissolved in 1 ml of formic acid 1%. The product purification was performed by reverse-phase RP-18 modified silica column chromatography using the following gradient: water (150 ml), 10% MeOH (150 ml), 20% MeOH (50 ml) and 50% MeOH (column wash). Each fraction was checked for the presence of adduct using a UV/vis detector. Fractions containing maxima at 232, 264 and 294 nm contained the adduct 10 were separated and lyophilized to dryness. Compound 10 (1.3 × 10 −2 g, 3.08 × 10 −5 mol) was obtained as oil in 33%. Cyclic Voltammetry --Solutions for cyclic voltammetry measurements had concentrations between 0.8 to 1.5 mM (0.9 for 1, 0.8 for 4, 1.5 for 3, 0.8 for 7, 0.9 for 8, 1.5 for 9, 0.9 for 10, 0.9 for 11 and 1.5 for 13) in 50 mM phosphate buffer (pH 7.4), as supporting electrolyte. A solution of K 4 [Fe(CN) 6 ]. 3H 2 O 1.5 × 10 −3 M and 0.1 M and NaCl was used for calibration. The sweep was performed between 1000 and −500 mV. Correlation of the Redox Potential of Compounds 3, 4 and 7 and Their Toxicity --The redox potential of compounds 3, 4 and 7 was plotted against their toxicity to rat cortical neurons. The toxicity data was obtained previously and published by our group, 17) and correspond to the neuronal viability of these cultures measured by the 3-(4,5-dimethylthiazol-2yl)-2,5-diphenyl tetrazolium bromide (MTT) assay. 
RESULTS

Chemical Synthesis
Hydrobromide salts of N-Me-α-MeDA (3) and α-MeDA (4) were prepared following the procedure of Borgman 22) and Pizarro 23) starting from the corresponding benzaldehyde and nitroethane. Their conjugate adducts with the bionucleophiles, GSH and NAC, 5-(GSH)-α-MeDA (7), 5-(GSH)-N-Me-α-MeDA (8), 5-(NAC)-α-MeDA (9), 5-(NAC)-N-Me-α-MeDA (10), were prepared by enzymatic oxidation according to previously published methods 26, 27) with modifications. Although the synthesis of adducts 8 and 10 are reported on literature 26, 28) they omit the complete structural elucidation as we here describe.
The enzymatic oxidation of 4 followed by GSH or NAC addition allowed the isolation of the newly synthesized adducts 2-(GSH)-α-MeDA (11) and 2-(NAC)-α-MeDA (12) (Fig. 2) . Compound, 5-OH-α-MeDA (13) was likewise prepared. Structural determination was based on the two dimensional NMR experiments that allowed the clear attribution of all the protons. The aromatic pattern for the 5-adducts (7-10) shows two singlets for each which agrees with the GSH and NAC covalently bonded at the 5-position. Also, the heteronuclear multiple bond correlation (HMBC) spectra showed the correlation between the aromatic C5 and the protons of cysteine β-CH 2 . As expected when the GSH or NAC are bonded to the 2 position the two remaining orto protons presents a pair of doublets with J = 8 Hz. Mass spectrometry agrees in all cases with the monoadduct formation.
Cyclic Voltammetry Studies
The synthesized MDMA metabolites 3 and 4 (as hydrobromide salts), its adducts 7 to 11 and also the related compound 13, were subjected to cyclic voltammetry studies and the results compared with those observed for the parent compound MDMA. The cyclic voltammetry of these compounds was conducted in a phosphate buffer at pH 7.4 (50 mM) at a sweep rate (ν) of 200 mV s −1 . Table 1 presents the oxidation potential of MDMA and its tested human metabolites as well as the related compound 13. The anodic scans showed peaks that correspond to the oxidation of the catecholamine derivatives and their GSH or NAC conjugated adduct (Figs. 3 and 4). As previously described for adrenaline, in a neutral buffer, the correspondent cathodic peaks remained unobserved. 29) As seen in Fig. 3 no redox reactivity was measurable for MDMA when subjected to the same potentials as its metabolites. The methylene group blocking the two hydroxyl groups prevents the compound from adopting the quinone structure. Compound 13 shows the lower oxidation potential (Fig. 3) which is due to the several hydroxyl groups that activate the aromatic ring to oxidation. Similar effects were observed on other catecholic systems such as 3,4-dihydroxybenzoic acid and 3,4,5-trihydroxybenzoic acid. 30) The conjugation with GSH or NAC at the 5 position slightly reduced the oxidation potential when compared with the non-conjugated amines (Table 1 -representative examples are presented at Fig. 4) . The effect of GSH conjugation at the 2-position is less noticeable.
A correlation between the oxidability of com- 
DISCUSSION
The key results of our study were: (a) synthesis and characterization of MDMA human metabolites, with special relevance for the newly synthesized 11 and 12 and, (b) evaluation of its redox properties and its relation with its potential to produce toxicity to rat cortical neurons.
Several studies failed to prove serotonergic neurotoxicity when MDMA and MDA where injected directly into the rat brain. 5, 31) Since the serotonergic neurotoxicity could not occur after the direct brain administration of the drugs, it was postulated that systemic metabolism is probably important for the occurrence of neurotoxic events, 6) even though, the possible direct or indirect over-stimulation of serotonergic and dopaminergic neurons associated with hyperthermia can also contribute to the neurotoxic effects of non-metabolized MDMA. 4, 32) The metabolism of MDMA and MDA leads to highly oxidative compounds -the catecholamines. These compounds can auto-oxidize with resultant disturbances in vivo. The o-quinone intermediates thus formed can cause cellular lesions, i.e., via covalent binding (quinones undergo Michael addition) or generate ROS via redox cycling -both of which can lead to toxicity. 10) The nucleophilicity of the cysteine sulfydryl groups renders protein and non-protein sulfydryls preferential targets for the quinone intermediates of the MDMA and MDA-metabolites. GSH is the major non-protein sulfydryl present in cells, and the reaction of it's SH group with quinones prevents the occurrence of irreversible modification of other intracellular nucleophilic sites. However, some polyphenolic-GSH conjugates, and their metabolites, retain the electrophilic and redox properties of the parent polyphenol. 33, 34) Indeed, the reactivity of the thioether metabolites may exceed that of the parent polyphenol. In biological media, α-MeDA undergoes oxidation to the corresponding o-quinone, which is conjugated with GSH 26, 35) to form 5-(GSH)-α-MeDA. This metabolite is readily oxidized to the o-quinone-GSH derivate, followed by subsequent addition of a second molecule of GSH to form 2,5-bis(glutathion-S-yl)-α-MeDA. 16) Capela et al. 17) have shown that 5-(GSH)-α-MeDA has a potent toxic effect in rat cortical neurons.
Fast-sweep electrochemical techniques were previously applied to the study of the oxidation pathways of catecholamines in vitro. These techniques allowed the positive identification of the transient intermediates, i.e., the open-chain oquinones, and the precise determination of the rate of intramolecular cyclization to the substituted indole as well as its subsequent oxidation to the aminochrome. 14) In accordance Carvalho et al. 20) have demonstrated in vitro that the concentration of N-Me-α-MeDA and α-MeDA decreases over time in biological media, due to their oxidation to the correspondent aminochromes.
Electrochemical oxidation of the catechol group has also been studied in the presence of secondary amines 36, 37) and mercaptotriazole 38) as nucleophiles. Common to these reports is the presence of one anodic and a corresponding cathodic peak on the cyclic voltammetry record of the catechol in buffered solution. These findings correspond to the transformation of the catechol to the corresponding o-benzoquinone and vice-versa, within a quasi reversible two electron transfer process. 36, 37) The oxidation of the catechol in the presence of a nucleophile (secondary amines or thiols) results in a 1,4-Michael addition reaction. The resulting compounds (amines and thio substituted catechols) are more easily oxidized than the parent starting molecule by virtue of the presence of an extra electron-donating group. 38) Recent studies on the electrochemical oxidation-reduction processes of adrenaline, studied by multi-mode in situ spectroelectrochemistry, found that the redox pathways were related to the pH of the solution, the potential window and the oxygen dissolved in the medium. 39) The formation of an o-quinone was invoked. These authors 29, 40) observed the scavenging of the o-quinone by L-cysteine with formation of adducts and also subsequent oxidation of these cysteinyl conjugates originate o-quinones that could further react with free L-cysteine yielding the corresponding bis-adducts. A similar behavior was observed for dopamine (DA), 15) although an electrochemical-chemical-electrochemical (ECE) reaction mechanism was proposed for the DA electrochemical oxidation with a subsequent polymerization of the resulting 5,6-indolequinone.
At the present working conditions, pH 7.4, the deprotonation of the o-quinone (14) , formed upon oxidation (2e − , 2H + ) of catecholamines, yields the neutral o-quinone (15) that undergo an intramolecular cyclization reaction (1,4-Michael addition) to give 5,6-dihydroxyindoline (16) . In solution this compound is oxidized by o-quinone (14) to the corresponding p-quinone imine (17) also designated as aminochrome (Fig. 6) . The reaction sequence occurs so fast that, after each scan reversal, a peak corresponding to the reversible reduction of o-quinone was never observed in the cyclic voltammograms for all the tested compounds. This observation has precedence in the literature. 14, 29) The only peak observed on the initial anodic sweep corresponds to the oxidation of the catecholamines and their GSH and NAC adducts to 14 ( Table 1 ) that rapidly deprotonates and cyclises to 16. This is in turn rapidly Fig. 3 ).
According to our results, α-MeDA (4) is more easily oxidized than N-Me-α-MeDA (3). Indeed, whereas the E p value for 3 is 420 mV, the corresponding E p for 4 is 349 mV i.e., a difference of 71 mV. Probably, the most obvious reason for this event may be the difference in the pK a of 4, a primary amine, versus 3, a secondary amine, bearing higher basicity. 41) It's known from literature 42, 43) that OH-N hydrogen bonding can have a profound effect in altering the oxidation potential of enols to lower values. At the pH of 7.4 used for the cyclic voltammetry experiments, 3 should exist preferentially as its hydrochloride salt and 4, partially in its free amine form, could be involved in intermolecular hydrogen bonding responsible for lowering the E p . However we should not exclude the involvement of other factors as solvation effects that may result in a higher stabilization of 3 in relation to 4.
From the results of Table 1 it is possible to conclude that the conjugation with GSH or NAC at the 5 position reduced the oxidation potential when compared with the non-conjugated amines. When the catechol moiety becomes attached to compounds like GSH or NAC the presence of a third heteroatom on the aromatic ring is the main contribution to the reduction of the redox potential and accounts for the difference on the E p observe for the cathecol thioeter adducts versus the parent catecholamines. In fact the highest value for the difference on the E p that is observed for the glutathione adducts (−189 and −121 mV for 8 vs. 3 and 7 vs. 4) highlights this explanation.
The voltammetric curve obtained for newly synthesized thioether adduct 11 shows that 2-GSH-α-MeDA (11) is more resistant to the oxidation than the parent catecholamine 4 (+43 mV for 4 vs. 11). Since 2-aducts are more stereochemical constrained than 5 adducts the adopted conformation of GSH chain should promote the stabilization of the catechol structure and prevent its oxidation to the quinone as described for the catechol NCQ-436, a metabolite of the antipsychotic remoxipride. 44) Noteworthy, the lower oxidation potential observed for the 5-GSH adducts of α-MeDA relative to the parent catecholamine correlates well with the higher toxicity of this adduct in rat cortical neurons. Accordingly, unlike N-Me-α-MeDA and α-MeDA, their systemically formed thioether conjugates are easily transported across the blood-brain barrier. 28) Studies in vivo show that intracerebroventricular (ICV) injections of 5-(GSH)-α-MeDA into rats produced neurobehavioral changes characteristic of peripheral administration of MDMA/MDA as well as acute increases in brain 5-HT and DA concentrations 45) and produced prolonged depletions in 5-HT similar to those obtained after peripheral administration of MDA and MDMA. 46) Moreover, recent experiments using in vivo microdialysis have provided direct evidence for the presence of GSH and NAC conjugates of MDMA metabolites in the brain after in vivo s.c. administration of MDMA. 28) This accounts for the importance that voltammetry studies may assume in predicting the potential neurotoxicity of MDMA and MDA-metabolites. It should be nevertheless emphasized that not only di-rect MDMA-metabolites toxicity contribute to the toxic events. Other factors, like the possible direct or indirect over-stimulation of serotonergic and dopaminergic neurons associated with hyperthermia also contribute to the neurotoxic effects of nonmetabolized MDMA.
In conclusions, oxidation of catecholamines can lead to the rapid formation of electrophilic and redox active quinones. These species are susceptible to alkylation by cellular nucleophiles (GSH, proteins, and DNA) and can undergo further oxidation. Our results show that there is a significant correlation between the redox behavior of the MDMA and MDA metabolites and their respective toxicity to rat cortical neurons.
